Cargando…
The gut microbial metabolite imidazole propionate inhibits metformin action
Imidazole propionate inhibits metformin action in a manner dependent on a p38γ‐Akt‐AMPK axis.[Image: see text]
Autores principales: | Sugawara, Kenji, Ogawa, Wataru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354508/ https://www.ncbi.nlm.nih.gov/pubmed/33949789 http://dx.doi.org/10.1111/jdi.13566 |
Ejemplares similares
-
New mechanism of metformin action mediated by lysosomal presenilin enhancer 2
por: Sugawara, Kenji, et al.
Publicado: (2022) -
Microbial Imidazole Propionate Affects Responses to Metformin through p38γ-Dependent Inhibitory AMPK Phosphorylation
por: Koh, Ara, et al.
Publicado: (2020) -
Mechanisms of metformin action: In and out of the gut
por: Minamii, Takahiro, et al.
Publicado: (2018) -
News in caecal signalling: the role of propionate in microbial-epithelial crosstalk
por: Stumpff, Friederike, et al.
Publicado: (2021) -
Structural characterization of the microbial enzyme urocanate reductase mediating imidazole propionate production
por: Venskutonytė, Raminta, et al.
Publicado: (2021)